Outcomes of Cardiac Contractility Modulation: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Background. Cardiac contractility modulation (CCM) is a device therapy for systolic heart failure (HF) in patients with narrow QRS. We aimed to perform an updated meta-analysis of the randomized clinical trials (RCTs) to assess the efficacy and safety of CCM therapy. Methods. We conducted a systemat...
Saved in:
| Main Authors: | Ramy Mando, Akshay Goel, Fuad Habash, Marwan Saad, Karam Ayoub, Srikanth Vallurupalli, Waddah Maskoun |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Cardiovascular Therapeutics |
| Online Access: | http://dx.doi.org/10.1155/2019/9769724 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modulation of Cardiac Contractility – a New Method in the Treatment of Heart Failure
by: A. A. Petrukhina, et al.
Published: (2016-11-01) -
Device‐therapy in chronic heart failure: Cardiac contractility modulation versus cardiac resynchronization therapy
by: Goekhan Yuecel, et al.
Published: (2025-02-01) -
Effects of cardiac contractility modulation on autophagy and apoptosis of cardiac myocytes in rabbits with chronic heart failure.
by: Qingqing Hao, et al.
Published: (2024-01-01) -
Myosin Modulators Mavacamten and Aficamten Inhibit Cardiac Contractility Through Different Mechanisms
by: Saffie Mohran, et al.
Published: (2025-06-01) -
Cardiac contractility modulation in patients with heart failure with reduced ejection fraction: a meta-analysis of Russian clinical trials
by: A. A. Safiullina, et al.
Published: (2025-04-01)